After Investing in Robots and Edible Crickets, Dentsu Looks to Cure Cancer
Posted in: Uncategorized
No one ever accused advertising of curing cancer before. Dentsu is looking to change that.
Since Dentsu Inc.’s venture capital fund launched two years ago, it has funded a few forward-looking startups, from a maker of household robots to a company that makes snack bars from crickets. Now the Japanese ad giant is getting even more ambitious. Unlike other agencies that have invested in making products like beer and candles, or even starting a barbershop, Dentsu is looking to heal people.
Dentsu said Tuesday it invested in Grail Inc., a Menlo Park, California biotech startup that is working on blood tests to try to catch cancer in its early stages. Dentsu Ventures, with an overall fund of $91 million, declined to say how much it had invested in Grail.
Post a Comment